Drotrecogin alfa (activated) in severe sepsis - Authors' reply

Andre C. Kalil; Steven P. LaRosa

doi:10.1016/S1473-3099(12)70350-X

Drotrecogin alfa (activated) in severe sepsis - Authors' reply

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	110-111
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	13
Issue number	2
DOIs	https://doi.org/10.1016/S1473-3099(12)70350-X
State	Published - Feb 2013

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(12)70350-X

Cite this

@article{f8119d1dcec843dc9d89ef5906b41ee9,

title = "Drotrecogin alfa (activated) in severe sepsis - Authors' reply",

author = "Kalil, {Andre C.} and LaRosa, {Steven P.}",

note = "Funding Information: SLR has received research grant support from Eisai, AstraZeneca, and Agennix, and has consulted for Artisan Pharma. AK has received research grant support from Eisai, AstraZeneca, and Agennix.",

year = "2013",

month = feb,

doi = "10.1016/S1473-3099(12)70350-X",

language = "English (US)",

volume = "13",

pages = "110--111",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "2",

}

TY - JOUR

T1 - Drotrecogin alfa (activated) in severe sepsis - Authors' reply

AU - Kalil, Andre C.

AU - LaRosa, Steven P.

N1 - Funding Information: SLR has received research grant support from Eisai, AstraZeneca, and Agennix, and has consulted for Artisan Pharma. AK has received research grant support from Eisai, AstraZeneca, and Agennix.

PY - 2013/2

Y1 - 2013/2

UR - http://www.scopus.com/inward/record.url?scp=84872574149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872574149&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(12)70350-X

DO - 10.1016/S1473-3099(12)70350-X

M3 - Letter

C2 - 23347628

AN - SCOPUS:84872574149

VL - 13

SP - 110

EP - 111

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 2

ER -

Drotrecogin alfa (activated) in severe sepsis - Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this